Hyaluronan (HA) is the major
glycosaminoglycan in the extracellular matrix. During
inflammation, there is an increased breakdown of HA, resulting in the accumulation of low molecular weight (LMW) HA and activation of monocytes and macrophages.
Eicosanoids, derived from the cytosolic
phospholipase A2 group IVA (cPLA2α) activation, are potent
lipid mediators also attributed to acute and chronic
inflammation. The aim of this study was to determine the effect of LMW HA on cPLA2α activation,
arachidonic acid (AA) release, and subsequent
eicosanoid production and to examine the receptors and downstream mechanisms involved in these processes in monocytes and differently polarized macrophages. LMW HA was a potent stimulant of AA release in a time- and dose-dependent manner, induced cPLA2α, ERK1/2, p38, and JNK phosphorylation, as well as activated COX2 expression and
prostaglandin (PG) E2 production in primary human monocytes, murine RAW 264.7, and wild-type bone marrow-derived macrophages. Specific cPLA2α inhibitor blocked HA-induced AA release and
PGE2 production in all of these cells. Using CD44, TLR4, TLR2, MYD88, RHAMM or STAB2
siRNA-transfected macrophages and monocytes, we found that AA release, cPLA2α, ERK1/2, p38, and JNK phosphorylation, COX2 expression, and
PGE2 production were activated by LMW HA through a TLR4/MYD88 pathway. Likewise,
PGE2 production and COX2 expression were blocked in Tlr4(-/-) and Myd88(-/-) mice, but not in Cd44(-/-) mice, after LMW HA stimulation. Moreover, we demonstrated that LMW HA activated the M1 macrophage phenotype with the unique cPLA2α/COX2(high) and COX1/ALOX15/ALOX5/LTA4H(low) gene and
PGE2/
PGD2/15-
HETE(high) and
LXA4(low)
eicosanoid profile. These findings reveal a novel link between HA-mediated
inflammation and lipid metabolism.